OIS VIRTUAL PUBLIC COMPANY SHOWCASE

July 16, 2020

Day
Hour
Minute
Second

12TH ANNUAL OIS 2020

NOVEMBER 12, 2020 | LAS VEGAS, NV

The Ophthalmology Innovation Summit began in 2009 and now unites over 1,200 Corporate, Clinical and Capital leaders to collaborate on the development and commercialization of innovative drugs, devices and diagnostics to address unmet vision disorders.

The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

LATEST NEWS

Keeping an "Eye on Innovation" Through News & Analysis

With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering

July 1 2020

With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering

Oyster Point Pharma has taken two big steps recently to advance development of its OC-01 nasal-spray candidate to treat dry eye disease: the closing of ...
Necessity Is the Mother of Collaborative Care between Optometrists and Ophthalmologists

June 17 2020

Necessity Is the Mother of Collaborative Care between Optometrists and Ophthalmologists

Collaborative care models – optometrists and ophthalmologists working together on patient care – are emerging as a way to reduce some of the strain caused ...
With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

June 10 2020

With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

Most transformations are predictable: A caterpillar will turn into a butterfly; a cell will be genetically altered should extraneous DNA enter its membrane. Predictable would ...
OIS-Index

June 3 2020

May Extends April’s Rebound from March Lows

The OIS Index of ophthalmic stocks gained 7.9% in May, following a 12.2% gain in April, extending the rebound from the mid-March lows. Over the ...
Has Promising Cannabinoid-Based Drug Development Finally Come to Ophthalmology?

June 3 2020

Has Promising Cannabinoid-Based Drug Development Finally Come to Ophthalmology?

Before Tetra Bio-Pharma's recent announcement of US Food and Drug Administration Orphan Drug Designation for its ophthalmic clinical program, ophthalmology was one of the few ...
Emerging Glaucoma Devices See Beyond IOP

May 27 2020

Emerging Glaucoma Devices See Beyond IOP

The glaucoma space has been dominated by a host of products designed to lower intraocular pressure (IOP) – minimally invasive glaucoma surgery (MIGS) devices and ...

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.